Results 151 to 160 of about 211,796 (270)
Control first, tolerance second: biologics as enablers of allergen immunotherapy in severe allergic asthma. [PDF]
Jentzsch B +8 more
europepmc +1 more source
Allergen immunotherapy for equine insect bite hypersensitivity: Does it reduce clinical signs?
Summary Insect bite hypersensitivity (IBH) is a common, recurrent allergic skin disease of horses. This critically appraised topic evaluated whether therapeutic allergen immunotherapy (AIT) reduces clinical signs in affected horses. Four databases were searched and five therapeutic clinical studies were retained.
R. Cao, E. Maina
wiley +1 more source
Adjuvant Strategies to Improve the Efficacy of Allergen Immunotherapy. [PDF]
Tabynov K, Tabynov K, Petrovsky N.
europepmc +1 more source
Interleukin‐12: Central Roles in Immune Regulation and Disease Therapy
IL‐12 levels are tightly regulated to balance effective protective immunity against infections and cancer with the risk of excessive inflammation and autoimmune disease. Both insufficient and excessive IL‐12 activity can therefore be detrimental, highlighting the importance of precisely controlling its production and signaling. ABSTRACT Interleukin‐12 (
Anthi Psoma, Geert van den Bogaart
wiley +1 more source
Clinical Evaluation of Allergen Immunotherapy for Allergic Rhinitis. [PDF]
Catamerò F +10 more
europepmc +1 more source
Tissue Resident Memory Cells: Friend or Foe?
Tissue‐resident memory T cells (TRM cells) are specialised immune cells in barrier tissues like the lungs, skin and gut, providing rapid host defence and tumour surveillance. Their retention and differentiation are regulated by molecules such as CD69, CD103 and TGF‐β. Dysregulation of TRM cells can lead to chronic activation, driving conditions such as
Chidimma F. Chude +2 more
wiley +1 more source
Criteria for Control and Remission of Respiratory Allergic Disease With Allergen Immunotherapy: A Delphi Consensus. [PDF]
González-Mancebo E +11 more
europepmc +1 more source
This systematic review establishes disease‐specific dysregulations of human innate lymphoid cells (ILCs), demonstrating that an ILC1/ILC3 imbalance compromises mucosal barriers in inflammatory bowel disease, while activated ILC2s drive allergic airway inflammation.
Luan F. Lückmann +7 more
wiley +1 more source
Sublingual allergen immunotherapy: evidence from randomized trials, real-world studies and meta-analyses. [PDF]
Paoletti G +16 more
europepmc +1 more source

